Trials / Recruiting
RecruitingNCT04711551
Clinical and Biomolecular Assessment for the Monitoring of Patients Undergoing Regenerative Medicine Treatments with Orthobiologics
Patients-reported Outcome Measures (PROMs), Clinical Objective and Biomolecular Assessment for the Monitoring of Patients Undergoing Regenerative Medicine Treatments with Orthobiologics
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Academic / Other
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
the aim is to improve the evaluation of the outcomes of regenerative medicine treatments performed in the regenerative medicine centers involved in the study. patients who undergo regenerative medicine treatments present acute and chronic pathologies of the musculoskeletal system, of the stomatological system and of the integuments. Objective pre, peri and post treatment evaluations are collected. A dedicated software collects the PROMs compiled by the patients, the objective clinical data and the biomolecular evaluations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | PRP and related devices to abtain platelet concentrate from whole blood, medullary and adipose tissue and related devices | PRP and related devices to abtain platelet concentrate from whole blood, medullary and adipose tissue and related devices |
Timeline
- Start date
- 2018-05-30
- Primary completion
- 2030-05-30
- Completion
- 2030-05-30
- First posted
- 2021-01-15
- Last updated
- 2025-02-17
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT04711551. Inclusion in this directory is not an endorsement.